As of 2024-12-11, the Relative Valuation of Entheon Biomedical Corp (ENBI.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.17 CAD, the upside of Entheon Biomedical Corp based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2024-12-09 | -4.89 |
| 2024-12-06 | -5.04 |
| 2024-12-05 | -4.61 |
| 2024-12-04 | -4.03 |
| 2024-12-03 | -3.89 |
| 2024-12-02 | -3.89 |
| 2024-11-27 | -4.03 |
| 2024-11-26 | -3.74 |
| 2024-11-25 | -3.17 |
| 2024-11-22 | -3.74 |
| 2024-11-21 | -3.74 |
| 2024-11-18 | -3.74 |
| 2024-11-15 | -4.46 |
| 2024-11-13 | -3.89 |
| 2024-11-08 | -3.89 |
| 2024-11-07 | -3.74 |
| 2024-11-06 | -3.74 |
| 2024-11-05 | -3.74 |
| 2024-11-04 | -3.60 |
| 2024-11-01 | -3.60 |
| 2024-10-30 | -3.17 |
| 2024-10-28 | -3.17 |
| 2024-10-25 | -3.02 |
| 2024-10-22 | -3.74 |
| 2024-10-21 | -4.17 |
| 2024-10-18 | -4.03 |
| 2024-10-17 | -4.32 |
| 2024-10-15 | -4.03 |
| 2024-10-10 | -4.61 |
| 2024-10-03 | -2.74 |
| 2024-09-27 | -2.88 |
| 2024-09-25 | -2.88 |
| 2024-09-24 | -3.02 |
| 2024-09-13 | -2.88 |